- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.
According to our latest study, the global Pets Anti-infective Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the China market, core pets anti-infective drugs manufacturers include Zoetis, Merck and Elanco etc. The Top 3 companies hold a share above 40%.
This report is a detailed and comprehensive analysis for global Pets Anti-infective Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Administration Method and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pets Anti-infective Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pets Anti-infective Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pets Anti-infective Drugs market size and forecasts, by Administration Method and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pets Anti-infective Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pets Anti-infective Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pets Anti-infective Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Merck, Elanco, Virbac and Dechra Veterinary Products, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Pets Anti-infective Drugs market is split by Administration Method and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Administration Method, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Administration Method
External Use
Internal Use
Injection
Market segment by Application
Dog
Cat
Others
Major players covered
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pets Anti-infective Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pets Anti-infective Drugs, with price, sales, revenue and global market share of Pets Anti-infective Drugs from 2018 to 2023.
Chapter 3, the Pets Anti-infective Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pets Anti-infective Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Administration Method and application, with sales market share and growth rate by administration method, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pets Anti-infective Drugs market forecast, by regions, administration method and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pets Anti-infective Drugs.
Chapter 14 and 15, to describe Pets Anti-infective Drugs sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Pets Anti-infective Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Administration Method
1.3.1 Overview: Global Pets Anti-infective Drugs Consumption Value by Administration Method: 2018 Versus 2022 Versus 2029
1.3.2 External Use
1.3.3 Internal Use
1.3.4 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Pets Anti-infective Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Dog
1.4.3 Cat
1.4.4 Others
1.5 Global Pets Anti-infective Drugs Market Size & Forecast
1.5.1 Global Pets Anti-infective Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pets Anti-infective Drugs Sales Quantity (2018-2029)
1.5.3 Global Pets Anti-infective Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Pets Anti-infective Drugs Product and Services
2.1.4 Zoetis Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Pets Anti-infective Drugs Product and Services
2.2.4 Merck Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 Elanco
2.3.1 Elanco Details
2.3.2 Elanco Major Business
2.3.3 Elanco Pets Anti-infective Drugs Product and Services
2.3.4 Elanco Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Elanco Recent Developments/Updates
2.4 Virbac
2.4.1 Virbac Details
2.4.2 Virbac Major Business
2.4.3 Virbac Pets Anti-infective Drugs Product and Services
2.4.4 Virbac Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Virbac Recent Developments/Updates
2.5 Dechra Veterinary Products
2.5.1 Dechra Veterinary Products Details
2.5.2 Dechra Veterinary Products Major Business
2.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Product and Services
2.5.4 Dechra Veterinary Products Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Dechra Veterinary Products Recent Developments/Updates
2.6 Ceva Santé Animale
2.6.1 Ceva Santé Animale Details
2.6.2 Ceva Santé Animale Major Business
2.6.3 Ceva Santé Animale Pets Anti-infective Drugs Product and Services
2.6.4 Ceva Santé Animale Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ceva Santé Animale Recent Developments/Updates
2.7 Vetoquinol
2.7.1 Vetoquinol Details
2.7.2 Vetoquinol Major Business
2.7.3 Vetoquinol Pets Anti-infective Drugs Product and Services
2.7.4 Vetoquinol Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Vetoquinol Recent Developments/Updates
2.8 Nanjing Jindun Animal
2.8.1 Nanjing Jindun Animal Details
2.8.2 Nanjing Jindun Animal Major Business
2.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Product and Services
2.8.4 Nanjing Jindun Animal Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Nanjing Jindun Animal Recent Developments/Updates
2.9 Wuhan Chopperlvya
2.9.1 Wuhan Chopperlvya Details
2.9.2 Wuhan Chopperlvya Major Business
2.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Product and Services
2.9.4 Wuhan Chopperlvya Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Wuhan Chopperlvya Recent Developments/Updates
2.10 Bimeda Animal Health
2.10.1 Bimeda Animal Health Details
2.10.2 Bimeda Animal Health Major Business
2.10.3 Bimeda Animal Health Pets Anti-infective Drugs Product and Services
2.10.4 Bimeda Animal Health Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bimeda Animal Health Recent Developments/Updates
2.11 Ouro Fino Saude
2.11.1 Ouro Fino Saude Details
2.11.2 Ouro Fino Saude Major Business
2.11.3 Ouro Fino Saude Pets Anti-infective Drugs Product and Services
2.11.4 Ouro Fino Saude Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Ouro Fino Saude Recent Developments/Updates
2.12 Norbrook
2.12.1 Norbrook Details
2.12.2 Norbrook Major Business
2.12.3 Norbrook Pets Anti-infective Drugs Product and Services
2.12.4 Norbrook Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Norbrook Recent Developments/Updates
3 Competitive Environment: Pets Anti-infective Drugs by Manufacturer
3.1 Global Pets Anti-infective Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pets Anti-infective Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Pets Anti-infective Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pets Anti-infective Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pets Anti-infective Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Pets Anti-infective Drugs Manufacturer Market Share in 2022
3.5 Pets Anti-infective Drugs Market: Overall Company Footprint Analysis
3.5.1 Pets Anti-infective Drugs Market: Region Footprint
3.5.2 Pets Anti-infective Drugs Market: Company Product Type Footprint
3.5.3 Pets Anti-infective Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pets Anti-infective Drugs Market Size by Region
4.1.1 Global Pets Anti-infective Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Pets Anti-infective Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Pets Anti-infective Drugs Average Price by Region (2018-2029)
4.2 North America Pets Anti-infective Drugs Consumption Value (2018-2029)
4.3 Europe Pets Anti-infective Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Pets Anti-infective Drugs Consumption Value (2018-2029)
4.5 South America Pets Anti-infective Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Pets Anti-infective Drugs Consumption Value (2018-2029)
5 Market Segment by Administration Method
5.1 Global Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2029)
5.2 Global Pets Anti-infective Drugs Consumption Value by Administration Method (2018-2029)
5.3 Global Pets Anti-infective Drugs Average Price by Administration Method (2018-2029)
6 Market Segment by Application
6.1 Global Pets Anti-infective Drugs Sales Quantity by Application (2018-2029)
6.2 Global Pets Anti-infective Drugs Consumption Value by Application (2018-2029)
6.3 Global Pets Anti-infective Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2029)
7.2 North America Pets Anti-infective Drugs Sales Quantity by Application (2018-2029)
7.3 North America Pets Anti-infective Drugs Market Size by Country
7.3.1 North America Pets Anti-infective Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Pets Anti-infective Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2029)
8.2 Europe Pets Anti-infective Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Pets Anti-infective Drugs Market Size by Country
8.3.1 Europe Pets Anti-infective Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Pets Anti-infective Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2029)
9.2 Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pets Anti-infective Drugs Market Size by Region
9.3.1 Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pets Anti-infective Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2029)
10.2 South America Pets Anti-infective Drugs Sales Quantity by Application (2018-2029)
10.3 South America Pets Anti-infective Drugs Market Size by Country
10.3.1 South America Pets Anti-infective Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Pets Anti-infective Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2029)
11.2 Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pets Anti-infective Drugs Market Size by Country
11.3.1 Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pets Anti-infective Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pets Anti-infective Drugs Market Drivers
12.2 Pets Anti-infective Drugs Market Restraints
12.3 Pets Anti-infective Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pets Anti-infective Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pets Anti-infective Drugs
13.3 Pets Anti-infective Drugs Production Process
13.4 Pets Anti-infective Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pets Anti-infective Drugs Typical Distributors
14.3 Pets Anti-infective Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Pets Anti-infective Drugs Consumption Value by Administration Method, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pets Anti-infective Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Major Business
Table 5. Zoetis Pets Anti-infective Drugs Product and Services
Table 6. Zoetis Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Pets Anti-infective Drugs Product and Services
Table 11. Merck Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. Elanco Basic Information, Manufacturing Base and Competitors
Table 14. Elanco Major Business
Table 15. Elanco Pets Anti-infective Drugs Product and Services
Table 16. Elanco Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Elanco Recent Developments/Updates
Table 18. Virbac Basic Information, Manufacturing Base and Competitors
Table 19. Virbac Major Business
Table 20. Virbac Pets Anti-infective Drugs Product and Services
Table 21. Virbac Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Virbac Recent Developments/Updates
Table 23. Dechra Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 24. Dechra Veterinary Products Major Business
Table 25. Dechra Veterinary Products Pets Anti-infective Drugs Product and Services
Table 26. Dechra Veterinary Products Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Dechra Veterinary Products Recent Developments/Updates
Table 28. Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table 29. Ceva Santé Animale Major Business
Table 30. Ceva Santé Animale Pets Anti-infective Drugs Product and Services
Table 31. Ceva Santé Animale Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Ceva Santé Animale Recent Developments/Updates
Table 33. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 34. Vetoquinol Major Business
Table 35. Vetoquinol Pets Anti-infective Drugs Product and Services
Table 36. Vetoquinol Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Vetoquinol Recent Developments/Updates
Table 38. Nanjing Jindun Animal Basic Information, Manufacturing Base and Competitors
Table 39. Nanjing Jindun Animal Major Business
Table 40. Nanjing Jindun Animal Pets Anti-infective Drugs Product and Services
Table 41. Nanjing Jindun Animal Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Nanjing Jindun Animal Recent Developments/Updates
Table 43. Wuhan Chopperlvya Basic Information, Manufacturing Base and Competitors
Table 44. Wuhan Chopperlvya Major Business
Table 45. Wuhan Chopperlvya Pets Anti-infective Drugs Product and Services
Table 46. Wuhan Chopperlvya Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Wuhan Chopperlvya Recent Developments/Updates
Table 48. Bimeda Animal Health Basic Information, Manufacturing Base and Competitors
Table 49. Bimeda Animal Health Major Business
Table 50. Bimeda Animal Health Pets Anti-infective Drugs Product and Services
Table 51. Bimeda Animal Health Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Bimeda Animal Health Recent Developments/Updates
Table 53. Ouro Fino Saude Basic Information, Manufacturing Base and Competitors
Table 54. Ouro Fino Saude Major Business
Table 55. Ouro Fino Saude Pets Anti-infective Drugs Product and Services
Table 56. Ouro Fino Saude Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Ouro Fino Saude Recent Developments/Updates
Table 58. Norbrook Basic Information, Manufacturing Base and Competitors
Table 59. Norbrook Major Business
Table 60. Norbrook Pets Anti-infective Drugs Product and Services
Table 61. Norbrook Pets Anti-infective Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Norbrook Recent Developments/Updates
Table 63. Global Pets Anti-infective Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Pets Anti-infective Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Pets Anti-infective Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Pets Anti-infective Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Pets Anti-infective Drugs Production Site of Key Manufacturer
Table 68. Pets Anti-infective Drugs Market: Company Product Type Footprint
Table 69. Pets Anti-infective Drugs Market: Company Product Application Footprint
Table 70. Pets Anti-infective Drugs New Market Entrants and Barriers to Market Entry
Table 71. Pets Anti-infective Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Pets Anti-infective Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Pets Anti-infective Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Pets Anti-infective Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Pets Anti-infective Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Pets Anti-infective Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Pets Anti-infective Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2023) & (K Units)
Table 79. Global Pets Anti-infective Drugs Sales Quantity by Administration Method (2024-2029) & (K Units)
Table 80. Global Pets Anti-infective Drugs Consumption Value by Administration Method (2018-2023) & (USD Million)
Table 81. Global Pets Anti-infective Drugs Consumption Value by Administration Method (2024-2029) & (USD Million)
Table 82. Global Pets Anti-infective Drugs Average Price by Administration Method (2018-2023) & (US$/Unit)
Table 83. Global Pets Anti-infective Drugs Average Price by Administration Method (2024-2029) & (US$/Unit)
Table 84. Global Pets Anti-infective Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Pets Anti-infective Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Pets Anti-infective Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Pets Anti-infective Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Pets Anti-infective Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Pets Anti-infective Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2023) & (K Units)
Table 91. North America Pets Anti-infective Drugs Sales Quantity by Administration Method (2024-2029) & (K Units)
Table 92. North America Pets Anti-infective Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Pets Anti-infective Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Pets Anti-infective Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Pets Anti-infective Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Pets Anti-infective Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Pets Anti-infective Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2023) & (K Units)
Table 99. Europe Pets Anti-infective Drugs Sales Quantity by Administration Method (2024-2029) & (K Units)
Table 100. Europe Pets Anti-infective Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Pets Anti-infective Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Pets Anti-infective Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Pets Anti-infective Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Pets Anti-infective Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Pets Anti-infective Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2023) & (K Units)
Table 107. Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Administration Method (2024-2029) & (K Units)
Table 108. Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Pets Anti-infective Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Pets Anti-infective Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2023) & (K Units)
Table 115. South America Pets Anti-infective Drugs Sales Quantity by Administration Method (2024-2029) & (K Units)
Table 116. South America Pets Anti-infective Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Pets Anti-infective Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Pets Anti-infective Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Pets Anti-infective Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Pets Anti-infective Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Pets Anti-infective Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Administration Method (2018-2023) & (K Units)
Table 123. Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Administration Method (2024-2029) & (K Units)
Table 124. Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Pets Anti-infective Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Pets Anti-infective Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Pets Anti-infective Drugs Raw Material
Table 131. Key Manufacturers of Pets Anti-infective Drugs Raw Materials
Table 132. Pets Anti-infective Drugs Typical Distributors
Table 133. Pets Anti-infective Drugs Typical Customers
List of Figures
Figure 1. Pets Anti-infective Drugs Picture
Figure 2. Global Pets Anti-infective Drugs Consumption Value by Administration Method, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pets Anti-infective Drugs Consumption Value Market Share by Administration Method in 2022
Figure 4. External Use Examples
Figure 5. Internal Use Examples
Figure 6. Injection Examples
Figure 7. Global Pets Anti-infective Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Pets Anti-infective Drugs Consumption Value Market Share by Application in 2022
Figure 9. Dog Examples
Figure 10. Cat Examples
Figure 11. Others Examples
Figure 12. Global Pets Anti-infective Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Pets Anti-infective Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Pets Anti-infective Drugs Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Pets Anti-infective Drugs Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Pets Anti-infective Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Pets Anti-infective Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Pets Anti-infective Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Pets Anti-infective Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Pets Anti-infective Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Pets Anti-infective Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Pets Anti-infective Drugs Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Pets Anti-infective Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Pets Anti-infective Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Pets Anti-infective Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Pets Anti-infective Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Pets Anti-infective Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Pets Anti-infective Drugs Sales Quantity Market Share by Administration Method (2018-2029)
Figure 29. Global Pets Anti-infective Drugs Consumption Value Market Share by Administration Method (2018-2029)
Figure 30. Global Pets Anti-infective Drugs Average Price by Administration Method (2018-2029) & (US$/Unit)
Figure 31. Global Pets Anti-infective Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Pets Anti-infective Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Pets Anti-infective Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Pets Anti-infective Drugs Sales Quantity Market Share by Administration Method (2018-2029)
Figure 35. North America Pets Anti-infective Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Pets Anti-infective Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Pets Anti-infective Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Pets Anti-infective Drugs Sales Quantity Market Share by Administration Method (2018-2029)
Figure 42. Europe Pets Anti-infective Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Pets Anti-infective Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Pets Anti-infective Drugs Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Pets Anti-infective Drugs Sales Quantity Market Share by Administration Method (2018-2029)
Figure 51. Asia-Pacific Pets Anti-infective Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Pets Anti-infective Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Pets Anti-infective Drugs Consumption Value Market Share by Region (2018-2029)
Figure 54. China Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Pets Anti-infective Drugs Sales Quantity Market Share by Administration Method (2018-2029)
Figure 61. South America Pets Anti-infective Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Pets Anti-infective Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Pets Anti-infective Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Pets Anti-infective Drugs Sales Quantity Market Share by Administration Method (2018-2029)
Figure 67. Middle East & Africa Pets Anti-infective Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Pets Anti-infective Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Pets Anti-infective Drugs Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Pets Anti-infective Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Pets Anti-infective Drugs Market Drivers
Figure 75. Pets Anti-infective Drugs Market Restraints
Figure 76. Pets Anti-infective Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Pets Anti-infective Drugs in 2022
Figure 79. Manufacturing Process Analysis of Pets Anti-infective Drugs
Figure 80. Pets Anti-infective Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
